CN115161358A - Fermentation process for improving 5-HTP yield - Google Patents
Fermentation process for improving 5-HTP yield Download PDFInfo
- Publication number
- CN115161358A CN115161358A CN202210949191.0A CN202210949191A CN115161358A CN 115161358 A CN115161358 A CN 115161358A CN 202210949191 A CN202210949191 A CN 202210949191A CN 115161358 A CN115161358 A CN 115161358A
- Authority
- CN
- China
- Prior art keywords
- glucose
- fermentation
- glycerol
- yield
- htp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 53
- 230000004151 fermentation Effects 0.000 title claims abstract description 53
- LDCYZAJDBXYCGN-VIFPVBQESA-N 5-hydroxy-L-tryptophan Chemical compound C1=C(O)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-VIFPVBQESA-N 0.000 title claims abstract description 48
- 239000000758 substrate Substances 0.000 claims abstract description 37
- 238000000034 method Methods 0.000 claims abstract description 32
- 229940000681 5-hydroxytryptophan Drugs 0.000 claims abstract description 27
- LDCYZAJDBXYCGN-UHFFFAOYSA-N oxitriptan Natural products C1=C(O)C=C2C(CC(N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-UHFFFAOYSA-N 0.000 claims abstract description 27
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 75
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 32
- 239000008103 glucose Substances 0.000 claims description 32
- 208000012788 shakes Diseases 0.000 claims description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 8
- 238000012258 culturing Methods 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 230000001502 supplementing effect Effects 0.000 claims description 7
- 239000002609 medium Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 5
- 239000001963 growth medium Substances 0.000 claims description 5
- 239000012137 tryptone Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 229910021591 Copper(I) chloride Inorganic materials 0.000 claims description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 3
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 3
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 claims description 3
- 229960002413 ferric citrate Drugs 0.000 claims description 3
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 claims description 3
- 238000011218 seed culture Methods 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 230000003213 activating effect Effects 0.000 claims description 2
- ADHFGLVXSIGCIG-UHFFFAOYSA-N diazanium sulfate hydrochloride Chemical compound [NH4+].[NH4+].Cl.[O-]S([O-])(=O)=O ADHFGLVXSIGCIG-UHFFFAOYSA-N 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 11
- 238000003786 synthesis reaction Methods 0.000 abstract description 11
- 239000000047 product Substances 0.000 abstract description 10
- 230000015572 biosynthetic process Effects 0.000 abstract description 8
- 239000006227 byproduct Substances 0.000 abstract description 8
- 239000002054 inoculum Substances 0.000 abstract description 7
- 230000008569 process Effects 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 5
- 238000000746 purification Methods 0.000 abstract description 3
- 150000003862 amino acid derivatives Chemical class 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 abstract description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 abstract description 2
- 230000009467 reduction Effects 0.000 abstract description 2
- 238000011081 inoculation Methods 0.000 description 11
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 9
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 9
- 108010069013 Phenylalanine Hydroxylase Proteins 0.000 description 6
- 102100038223 Phenylalanine-4-hydroxylase Human genes 0.000 description 6
- 239000002131 composite material Substances 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241001052560 Thallis Species 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 241000219726 Griffonia simplicifolia Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- BIGPRXCJEDHCLP-UHFFFAOYSA-N ammonium bisulfate Chemical compound [NH4+].OS([O-])(=O)=O BIGPRXCJEDHCLP-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000008058 pain sensation Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 238000012807 shake-flask culturing Methods 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/22—Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
- C12P13/227—Tryptophan
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention discloses a fermentation process for improving the yield of 5-HTP, and belongs to the field of production of amino acid derivatives. According to the fermentation process of the 5-HTP yield, the inoculum size is increased, the activity of the strain at the early stage of fermentation is enhanced, the fermentation lag phase is reduced, and the strain is accelerated to enter the logarithmic phase, so that the synthesis of the strain to the product is facilitated; on the other hand, the compound substrate is supplemented, the synthesis of cofactors (NADH and the like) in the product synthesis process is increased, the product yield can be effectively improved, and meanwhile, the reduction of byproducts also lightens the difficulty and the cost of the subsequent purification process to a certain extent, so that the yield of the 5-hydroxytryptophan reaches 4.78g/L. The benefits are improved, and the cost is reduced.
Description
Technical Field
The invention relates to a fermentation process for improving the yield of 5-HTP, and belongs to the field of production of amino acid derivatives.
Background
5-HTP, 5-hydroxytryptophan, chemical name 5-hydroxy-3-indolyl-a-aminopropionic acid, molecular formula C 11 H 12 N 2 O 3 Molecular weight is 220.23.5-HTP is a ginsengNatural amino acids synthesized with proteins. In mammals, 5-HTP is a precursor of the neurotransmitters serotonin and melatonin, has a regulating effect on physiological functions such as sleep, pain sensation, body temperature, appetite and behavior, and has been successfully used for the treatment of diseases such as depression, insomnia and migraine due to its good biological and pharmacological properties and advantages of safety and stability.
At present, the preparation method of 5-hydroxytryptophan mainly comprises plant extraction method, chemical synthesis method and fermentation method, wherein the 5-hydroxytryptophan produced and prepared on a large scale is basically extracted from Griffonia simplicifolia seeds. However, the raw material of the gardner seeds is mainly from western african countries such as gardner, cotdetwa and dorgo, so that the cost and process of the plant extraction method are greatly influenced by the raw material, and the large-scale industrial production of 5-hydroxytryptophan is severely limited. The chemical synthesis method has complex process, low yield and high cost, so the method is not suitable for large-scale production. Compared with a plant extraction method, the fermentation method is not limited by raw materials, and in addition, compared with a chemical synthesis method, the process route is simpler, the production period is shorter, and the cost is lower, so that the method for preparing the 5-hydroxytryptophan by the fermentation method has natural advantages compared with other two methods.
At present, researchers at home and abroad are always dedicated to research on the preparation of 5-hydroxytryptophan by a fermentation method, but the fermentation level of the 5-hydroxytryptophan is still low, so that great influence is caused on the industrialization promotion of the 5-hydroxytryptophan, and the analysis reason is mainly two points, namely, the fermentation yield and the content of the 5-hydroxytryptophan are low; on the other hand, the content of the remaining tryptophan in the fermentation system is higher, which can adversely affect the subsequent separation and purification. In order to solve the problems, CN113493761A and CN113373103A increase the yield of 5-HTP by changing the concentration of metal ions or reducing dissolved oxygen, the highest yield respectively reaches 2.6g/L and 1.93g/L, although the yield is improved, the improvement is relatively limited, and the yield is still at a lower level in large-scale industrial production; in addition, CN113563251A discloses a method for separating and extracting 5-hydroxytryptophan from escherichia coli fermentation liquor, the extraction steps of the method comprise fermentation liquor obtaining, thallus separation, pigment separation, byproduct separation, protein separation and drying to obtain a product, and the yield of 5-HTP is lower to 55% due to overhigh content of the byproduct tryptophan in the fermentation liquor, so that the industrial development of the 5-HTP is influenced.
Disclosure of Invention
[ problem ] to
The invention aims to provide a fermentation process for improving the yield of 5-HTP.
[ solution ]
In order to solve the above problems, the technical scheme provided by the invention is as follows:
the fermentation process for improving the yield of the 5-HTP provided by the invention has the advantages that on one hand, the activity of the strain is further increased, the fermentation lag phase is shortened, and the inoculation amount of seeds in a tank is changed; on the other hand, the product yield is effectively improved and the byproduct content is reduced by supplementing the mixed substrate after induction and controlling the supplementing rate.
The invention provides a method for fermenting 5-HTP, which comprises the following steps:
(1) Activating the 5-hydroxytryptophan producing strain;
(2) Inoculating the activated strain into a seed culture medium to be cultured into a secondary seed solution;
(3) Adding the secondary seed liquid into a fermentation tank according to the amount of 5-20% (v/v), culturing at 35-40 ℃, feeding glucose after the initial sugar in the fermentation system is completely consumed, and culturing to OD 600 Not less than 30 ℃, reducing the culture temperature to 30 ℃, supplementing 1% of arabinose at one time, and simultaneously feeding a mixed substrate of glucose and glycerol at a speed of 4-6 mL/L/h.
In one embodiment, the 5-Hydroxytryptophan-producing strain is a recombinant E.coli expressing Phenylalanine 4-Hydroxylase (P4H) from a prokaryotic microorganism, disclosed in Yuheng Lin et al, engineering Bacterial Phenylalanine 4-Hydroxylase for Microbial Synthesis of Human neuron Precursor 5-Hydroxytryptophan, ACS Synth.Biol., just Accepted Manual Publication Date (Web): 17Jun2014, downloaded from tp:// pubs. Acids.org on Jun 24,2014.
In one embodiment, the 5-HTP-producing strain containment tube is removed from the-80 ℃ freezer and the activated strain is streaked.
In one embodiment, a single clone is picked from the streaking plate, added to a primary seed shake flask, and after overnight incubation, the primary shake flask is inoculated with seed from a secondary shake flask and incubated to OD 600 =1±0.2。
In one embodiment, glucose is fed at a concentration of 50% (w/v) to the OD of the fermentation system after the initial sugar in the fermentation system is consumed 600 Not less than 30.
In one embodiment, the mixed substrate of glucose and glycerol is prepared by mixing glucose at a concentration of 20% to 50% (w/v) and glycerol at an equal volume ratio of 20% to 80% (w/v).
In one embodiment, the pH of the fermentation system is maintained at 7.0 + -0.5 for not less than 72h.
Preferably, the secondary seed liquid is added to the fermentor in an amount of 15% (v/v).
Preferably, the mixed substrate of glucose and glycerol is prepared by mixing glucose with a concentration of 50% (w/v) and glycerol with an equal volume ratio of 50%.
Preferably, the mixed substrate of glucose and glycerol is fed at a rate of 4 mL/L/h.
In one embodiment, the streaking plate medium (g/L) is: tryptone 5, yeast powder 15, naCl 20 and agar powder 15.
In one embodiment, the seed shake flask medium (g/L) is: tryptone 5, yeast powder 15 and NaCl 20;
in one embodiment, the fermentation medium (g/L) is: glucose 20,KH 2 PO 4 12,(NH 4 ) 2 SO 4 6,MgSO 4 .7H 2 O2, citric acid 5; EDTA 8.4, coCl 2 ·6H 2 O 2.5,MnCl 2 ·4H 2 O 15.0,CuCl 2 ·2H 2 O 1.5,H 3 BO 3 3.0,Na 2 MoO 4 ·2H 2 O 2.5,ZnSO 4 13.0, ferric citrate 100, hydrochloric acidAmmonium sulfate 4.5, feSO 4 ·7H 2 O8.0; the pH was maintained at about 7.0 using ammonia.
[ advantageous effects ]
According to the fermentation process of the 5-HTP yield, provided by the invention, the inoculum size is increased, the strain activity at the early stage of fermentation is enhanced, the fermentation lag phase is reduced, and the strain is accelerated to enter the logarithmic growth phase, so that the synthesis of a product by the strain is facilitated; on the other hand, the compound substrate is supplemented, the synthesis of cofactors (NADH and the like) in the product synthesis process is increased, the product yield can be effectively improved, and meanwhile, the reduction of byproducts also lightens the difficulty and the cost of the subsequent purification process to a certain extent, so that the yield of the 5-hydroxytryptophan reaches 4.78g/L. The benefits are improved, and the cost is reduced.
Drawings
FIG. 1 is a flow diagram of 5-HTP fermentation.
Detailed Description
The method used in the following examples to detect 5-hydroxytryptophan and tryptophan was: 5-hydroxytryptophan and tryptophan are simultaneously detected by HPLC, a chromatographic column used by HPLC is InfinityLab poroschel HPH-C18.6 x 150mm, a mobile phase is 75% of water and 25% of methanol, the flow rate is 1ml/min, the sample loading amount is 10uL, the detection wavelength is 254nm, the sample preparation concentration is 0.1g/L, the column temperature is 30 ℃, and the time is 15min, wherein the peak time of 5-hydroxytryptophan is 4min, and the peak time of tryptophan is 7.5min.
In the examples described below, the recombinant Escherichia coli capable of synthesizing 5-Hydroxytryptophan is a recombinant Escherichia coli expressing Phenylalanine 4-Hydroxylase (P4H) of prokaryotic Microbial origin (disclosed in Yuheng Lin et al, engineering Bacterial Phenylalanine 4-Hydroxylase for Microbial Synthesis of Human neuron preferer 5-Hydroxytryptophan, ACS Synth. Biol., just Accepted amplified Manual Publication Date (Web): 17Jun2014, downloaded from tp:// pubs. Acids. Org on June 24,2014) capable of converting tryptophan to 5-Hydroxytryptophan.
Examples1
A fermentation process for improving the yield of 5-HTP comprises the following specific steps:
(1) Activation culture: taking out a 5-HTP production strain protecting tube from a refrigerator at the temperature of-80 ℃, and streaking an activated strain on a plate, wherein a streaking plate culture medium (g/L) is as follows: tryptone 5, yeast powder 15, naCl 20 and agar powder 15;
(2) Seed culture: selecting a single clone in a streak plate, adding a first-stage seed shake flask, culturing overnight, and inoculating the seed solution of the first-stage shake flask to a second-stage shake flask according to the inoculation amount of 1%; second-stage shake culture to logarithmic growth phase of thallus, that is, concentration OD of thallus in seed 600 The culture medium can be inoculated into the fermentation tank when the concentration is about 1.0.
The seed shake flask culture medium (g/L) is: tryptone 5, yeast powder 15 and NaCl 20;
(3) Fermentation culture: inoculating the secondary seed to a fermenter at 15% (V/V) inoculum size, continuously culturing at 37 deg.C, continuously adding 50% (W/V) glucose at 6mL/L/h when the initial sugar is consumed, and culturing at OD 600 At a temperature of 30 ℃ or more, the culture temperature was lowered to 30 ℃ while supplementing arabinose at a final concentration of 1% (g/100 mL) and 50% (W/V) glucose to 50% (V/V) glycerol and 50% (W/V) glucose in a ratio of 1:1, gradually reducing the feeding rate of the mixed substrate obtained by mixing from 6mL/L/h to 4mL/L/h, sampling on time, and fermenting for 72h to obtain fermentation liquor;
the fermentation medium (g/L) is: glucose 20,KH 2 PO 4 12,(NH 4 ) 2 SO 4 6,MgSO 4 .7H 2 O2, citric acid 5; EDTA 8.4, coCl 2 ·6H 2 O 2.5,MnCl 2 ·4H 2 O 15.0,CuCl 2 ·2H 2 O 1.5,H 3 BO 3 3.0,Na 2 MoO 4 ·2H 2 O 2.5,ZnSO 4 13.0, ferric citrate 100, ammonium sulfate hydrochloride 4.5 4 ·7H 2 O8.0; the pH was maintained at about 7.0 using ammonia.
Examples2
The fermenter inoculum size was changed to 5% on the basis of example 1, and the remaining conditions were unchanged.
Examples3
The fermenter inoculum size was changed to 10% on the basis of example 1, and the remaining conditions were unchanged.
Examples4
The fermenter inoculum size was changed to 20% on the basis of example 1, and the remaining conditions were unchanged.
TABLE 1 Effect of different inoculum sizes on fermentation yields and Strain concentrations
As can be seen from Table 1, the difference of the inoculation amount has a great influence on the fermentation yield, and the yield of 5-hydroxytryptophan shows a trend of increasing first and then decreasing with the increase of the fermentation inoculation amount. And from the density OD of the cells 600 It can be seen that the delay period of the thallus fermentation can be obviously increased by low inoculation amount (5%), so that the later induction time is delayed, and the integral yield is limited; and the high inoculation amount (20%) effectively shortens the lag phase of the thalli, and the thalli can grow to a higher concentration in a shorter time after inoculation, so that the induction time is advanced, but the later fermentation data shows that the excessively high inoculation amount can cause the activity of strains in the middle and later stages of fermentation to be reduced, and the density of the thalli is obviously reduced. In addition, in view of the fermentation yield, too high inoculation amount of the bacterial cells failed to further increase the yield of 5-hydroxytryptophan. And in the embodiment 1 (15% inoculation amount), a better improvement effect is achieved, the fermentation lag phase is reduced to a certain extent, the strain activity is not reduced in advance in the later period, and the strain productivity is also greatly improved.
Examples5
The feed substrate was changed on the basis of example 1 to 20% (W/V) glucose and 50% (V/V) glycerol at a ratio of 1:1 the resulting mixed substrate was mixed, and the remaining conditions were not changed.
Examples6
The feed substrate was changed on the basis of example 1 to 30% (W/V) glucose and 50% (V/V) glycerol at a ratio of 1:1 the resulting mixed substrate was mixed, and the remaining conditions were unchanged.
Examples7
The feed substrate was changed on the basis of example 1 to 40% (W/V) glucose and 50% (V/V) glycerol at a ratio of 1:1 the resulting mixed substrate was mixed, and the remaining conditions were unchanged.
Examples8
The feed substrate was changed on the basis of example 1 to 50% (W/V) glucose and 20% (V/V) glycerol at a ratio of 1:1 the resulting mixed substrate was mixed, and the remaining conditions were unchanged.
Examples9
The feed substrate was changed on the basis of example 1 to 50% (W/V) glucose and 60% (V/V) glycerol at a ratio of 1:1 the resulting mixed substrate was mixed, and the remaining conditions were not changed.
Examples10
The feed substrate was changed on the basis of example 1 to 50% (W/V) glucose and 80% (V/V) glycerol in a ratio of 1:1 the resulting mixed substrate was mixed, and the remaining conditions were unchanged.
Examples11
The feed substrate was changed on the basis of example 1 to 50% (W/V) glucose and 100% glycerol at a 1:1 the resulting mixed substrate was mixed, and the remaining conditions were unchanged.
TABLE 2 Effect of different substrate concentrations on fermentation yield
As can be seen from Table 2, when the glucose concentration is lower, the 5-hydroxytryptophan produced by fermentation and the tryptophan production are lower, and the product concentration shows a tendency to increase with the increase of the glucose concentration. When the concentration of glycerol is higher, the yield of the product is not greatly improved and even tends to be reduced, and the content of the byproduct tryptophan is increased along with the increase of the concentration of the glycerol. Finally, it was found that 50% (W/V) glucose and 50% (V/V) glycerol in example 1 were mixed in a ratio of 1:1 the mixed substrate obtained by mixing is fed-batch relatively to have better effect. Therefore, the flow acceleration rate was investigated on the basis of this optimized feed substrate.
Examples12
The feeding rate of the composite substrate was changed to 1mL/L/h based on example 1, and the rest conditions were unchanged.
Examples13
The feeding rate of the composite substrate was changed to 2mL/L/h based on example 1, and the rest conditions were unchanged.
Examples14
The feeding rate of the composite substrate was changed to 3mL/L/h based on example 1, and the rest conditions were unchanged.
TABLE 3 Effect of different substrate feed rates on fermentation yield
As can be seen from Table 3, the 5-hydroxytryptophan production increased with the increase of the substrate feed rate. The increase of the substrate feeding rate can effectively improve the growth of microorganisms, the increase of the bacterial quantity can effectively improve the yield to a certain extent, in addition, the feeding rate is improved, the glycerol supplementation amount is also improved to a certain extent, the glycerol can provide a certain cofactor (reducing power) in the metabolic process, and the level of the reducing power in the catalytic process of hydroxylase can be further improved and enhanced through metabolic balance adjustment, so that the content of the byproduct tryptophan is effectively reduced.
In conclusion, the invention greatly improves the whole yield of the 5-hydroxytryptophan by improving the inoculation amount, supplementing the composite substrate and simultaneously controlling the components and the supplementing rate of the composite substrate in the later period, and simultaneously reduces the generation of byproducts to a certain extent, thereby being a better process which is worth reference and application.
Although the present invention has been described with reference to the preferred embodiments, it should be understood that various changes and modifications can be made therein by one skilled in the art without departing from the spirit and scope of the invention as defined by the appended claims.
Claims (10)
1. A method of fermenting 5-HTP, said method comprising:
(1) Activating the strain producing 5-hydroxytryptophan;
(2) Inoculating the activated strain into a seed culture medium to be cultured into a secondary seed solution;
(3) Adding the secondary seed liquid into a fermentation tank according to the amount of 5-20% (v/v), culturing at 35-40 ℃, feeding glucose after the initial sugar in the fermentation system is completely consumed, and culturing to OD 600 Not less than 30 ℃, reducing the culture temperature to 28-30 ℃, supplementing 1% -5% of arabinose at one time, and simultaneously feeding a mixed substrate containing glucose and glycerol at a speed of 4-6 mL/L/h.
2. The method of claim 1, wherein the activated strain is added to a primary seed shake flask, and after overnight cultivation, the seeds from the primary shake flask are inoculated into a secondary shake flask and cultivated to OD 600 =1±0.2。
3. The method according to claim 1 or 2, wherein glucose is fed at a concentration of 50% (w/v) to OD in the fermentation system after the initial sugar in the fermentation system is consumed 600 Not less than 30.
4. The method according to any one of claims 1 to 3, wherein the mixed substrate of glucose and glycerol is prepared by mixing glucose at a concentration of 20% to 50% (w/v) and glycerol at an equal volume ratio of 20% to 80% (w/v).
5. The method according to any one of claims 1 to 4, wherein the pH of the fermentation system is maintained at 7.0. + -. 0.5, and the fermentation time is not less than 72 hours.
6. The method according to any one of claims 1 to 5, wherein the secondary seed liquid is added to the fermentor in an amount of 15% (v/v).
7. The method according to any one of claims 1 to 6, wherein the mixed substrate of glucose and glycerol is prepared by mixing glucose at a concentration of 50% (w/v) and glycerol at an equal volume ratio of 50%.
8. The method according to any one of claims 1 to 7, wherein the mixed substrate of glucose and glycerol is fed at a rate of 4 mL/L/h.
9. The method according to any one of claims 1 to 8, wherein the ratio of seed shake flask medium (g/L): tryptone 5.0-10.0, yeast powder 15.0-30.0 and NaCl 20.0-40.0.
10. The method according to any one of claims 1 to 9, wherein the fermentation medium (g/L): 15.0 to 20.0 portions of glucose and KH 2 PO 4 10.0~12.0,(NH 4 ) 2 SO 4 3~6,MgSO 4 .7H 2 1.0 to 2.0 percent of O and 2 to 5 percent of citric acid; EDTA 7 to 9, coCl 2 ·6H 2 O 1~5,MnCl 2 ·4H 2 O 10.0~20.0,CuCl 2 ·2H 2 O 1.0~3.0,H 3 BO 3 1.0~3.0,Na 2 MoO 4 ·2H 2 O 1.5~3.5,ZnSO 4 10.0 to 15.0 percent, 90.0 to 110.0 percent of ferric citrate, 3.5 to 5.5 percent of ammonium sulfate hydrochloride 4 ·7H 2 O 5.0~10.0。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210949191.0A CN115161358A (en) | 2022-08-09 | 2022-08-09 | Fermentation process for improving 5-HTP yield |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210949191.0A CN115161358A (en) | 2022-08-09 | 2022-08-09 | Fermentation process for improving 5-HTP yield |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115161358A true CN115161358A (en) | 2022-10-11 |
Family
ID=83480287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210949191.0A Pending CN115161358A (en) | 2022-08-09 | 2022-08-09 | Fermentation process for improving 5-HTP yield |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115161358A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170240939A1 (en) * | 2014-05-16 | 2017-08-24 | University Of Georgia Research Foundation, Inc. | Microbial approach for the production of 5-hydroxytryptophan |
| CN113373103A (en) * | 2021-06-18 | 2021-09-10 | 天津科技大学 | Method for improving yield of 5-hydroxytryptophan |
-
2022
- 2022-08-09 CN CN202210949191.0A patent/CN115161358A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170240939A1 (en) * | 2014-05-16 | 2017-08-24 | University Of Georgia Research Foundation, Inc. | Microbial approach for the production of 5-hydroxytryptophan |
| CN113373103A (en) * | 2021-06-18 | 2021-09-10 | 天津科技大学 | Method for improving yield of 5-hydroxytryptophan |
Non-Patent Citations (2)
| Title |
|---|
| YUHENG LIN等: "Engineering Bacterial Phenylalanine 4‑Hydroxylase for Microbial Synthesis of Human Neurotransmitter Precursor 5‑Hydroxytryptophan", ACS SYNTH. BIOL., vol. 3, 17 July 2014 (2014-07-17), pages 497 * |
| 王海蛟: "代谢工程改造大肠杆菌合成5-羟基色氨酸的研究", 中国博士学位论文全文数据库基础科学辑, 15 March 2020 (2020-03-15), pages 84 - 87 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105420417B (en) | Coenzyme Q10 Fermentation Production Process Based on Synergistic Control of Online Oxygen Consumption Rate and Conductivity | |
| CN102021214A (en) | Oxygen consumption rate-based vitamin B12 fermentation production control process | |
| DK180437B1 (en) | Method for Fermentative Production of Oxidized Coenzyme Q10 and High-content Oxidized Coenzyme Q10 Prepared therefrom | |
| CN107058414B (en) | Method for preparing L-alanine | |
| CN117947119B (en) | A fermentation method for a mixture of tetraacetyl phytosphingosine and triacetyl dihydrosphingosine | |
| CN106834377A (en) | A kind of method for producing epothilone B | |
| CN115161358A (en) | Fermentation process for improving 5-HTP yield | |
| CN112501221A (en) | Method for improving conversion rate of threonine and saccharic acid | |
| CN112430633A (en) | Process for producing arginine by using fed-batch culture solution for fermentation | |
| CN108048503B (en) | Method for improving ansamitocin P-3production | |
| CN102127572B (en) | Method for producing mycophenolic acid from penicillium brevicompactum by high-efficiency accumulation | |
| CN114686531B (en) | Method for preparing 1,3-propanediol by biotransformation | |
| CN101012470A (en) | Method for zymolytic production of S-adenosine methionine | |
| CN116987743A (en) | A process for producing γ-aminobutyric acid based on silkworm chrysalis powder coupled with glucose-controlled acid | |
| CN115948311A (en) | Genetically engineered bacterium for producing 5-hydroxytryptophan and construction method and application thereof | |
| CN102399845A (en) | Production control process of vitamin B12 fermentation based on CO2 concentration in tail gas | |
| CN120400079B (en) | Application of isoeugenol monooxygenase mutant in isoeugenol vanillin production | |
| CN119570866B (en) | A method for reducing acetic acid during succinic acid fermentation | |
| CN118562922B (en) | A method for producing dexamethasone epoxy hydrolysate by microbial fermentation | |
| CN119331923B (en) | Method for preparing trans-aconitic acid by using aspergillus terreus fermentation and application thereof | |
| CN113201563B (en) | A kind of nutrient salt and its application for improving the yield of Sclerotinia polysaccharide | |
| CN118006645B (en) | A quaternary pyrimidine gene cluster derived from halophilic bacillus, mutants and applications | |
| US10774350B2 (en) | Method for fermentative production of oxidized coenzyme Q10 | |
| CN121046482A (en) | A high-yield fermentation method and fermentation medium for nimocriptine | |
| CN111876446B (en) | Process for preparing L-malic acid by fermenting aspergillus oryzae |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |